APO Research

APO RESEARCH · REPORT

Esomeprazole Capsule

Selected research

Industry Growth & Trends

Global Esomeprazole Capsule Industry Growth and Trends Forecast to 2032

Market perspective

The global Esomeprazole Capsule market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Esomeprazole Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Esomeprazole Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Esomeprazole Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Esomeprazole Capsule include Teva., Sandoz, Sanofi, Novartis, Mylan, Stada, Saval Pharmaceutical, Mepha and KernPharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Esomeprazole Capsule market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Esomeprazole Capsule market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Esomeprazole Capsule market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Esomeprazole Capsule.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Esomeprazole Capsule market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Esomeprazole Capsule Market by Company

Teva.

Sandoz

Sanofi

Novartis

Mylan

Stada

Saval Pharmaceutical

Mepha

KernPharm

Garmish Pharmaceuticals

CQ Lummy

Blaskov

AstraZeneca AB

Actavis

Esomeprazole Capsule Segment by Type

Short-Term Use

Long-Term Use

Esomeprazole Capsule Segment by Application

Duodenal Ulcers

Gastroesophageal Reflux Disease

Others

Esomeprazole Capsule Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Esomeprazole Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Esomeprazole Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Esomeprazole Capsule.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Esomeprazole Capsule manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Esomeprazole Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Short-Term Use Table 2. Major Company of Long-Term Use Table 3. Global Esomeprazole Capsule Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Esomeprazole Capsule Sales by Type (2021-2026) & (K Pcs) Table 5. Global Esomeprazole Capsule Sales Market Share in Volume by Type (2021-2026) Table 6. Global Esomeprazole Capsule Sales by Type (2021-2026) & (US$ Million) Table 7. Global Esomeprazole Capsule Sales Market Share in Value by Type (2021-2026) Table 8. Global Esomeprazole Capsule Price by Type (2021-2026) & (US$/pc) Table 9. Global Esomeprazole Capsule Sales by Type (2027-2032) & (K Pcs) Table 10. Global Esomeprazole Capsule Sales Market Share in Volume by Type (2027-2032) Table 11. Global Esomeprazole Capsule Sales by Type (2027-2032) & (US$ Million) Table 12. Global Esomeprazole Capsule Sales Market Share in Value by Type (2027-2032) Table 13. Global Esomeprazole Capsule Price by Type (2027-2032) & (US$/pc) Table 14. North America Esomeprazole Capsule Sales by Type (2021-2026) & (K Pcs) Table 15. North America Esomeprazole Capsule Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Esomeprazole Capsule Sales by Type (2021-2026) & (K Pcs) Table 17. Europe Esomeprazole Capsule Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Esomeprazole Capsule Sales by Type (2021-2026) & (K Pcs) Table 19. Asia-Pacific Esomeprazole Capsule Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Esomeprazole Capsule Sales by Type (2021-2026) & (K Pcs) Table 21. Latin America Esomeprazole Capsule Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Esomeprazole Capsule Sales by Type (2021-2026) & (K Pcs) Table 23. Middle East and Africa Esomeprazole Capsule Sales by Type (2021-2026) & (US$ Million) Table 24. Esomeprazole Capsule Industry Trends Table 25. Esomeprazole Capsule Industry Drivers Table 26. Esomeprazole Capsule Industry Opportunities and Challenges Table 27. Esomeprazole Capsule Industry Restraints Table 28. Global Esomeprazole Capsule Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Esomeprazole Capsule Revenue Market Share by Company (2021-2026) Table 30. Global Esomeprazole Capsule Sales by Company (2021-2026) & (K Pcs) Table 31. Global Esomeprazole Capsule Sales Share by Company (2021-2026) Table 32. Global Esomeprazole Capsule Market Price by Company (2021-2026) & (US$/pc) Table 33. Global Esomeprazole Capsule Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Esomeprazole Capsule Major Company Production Sites and Headquarters Table 35. Global Esomeprazole Capsule Company, Product Type & Application Table 36. Global Esomeprazole Capsule Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Esomeprazole Capsule by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Esomeprazole Capsule Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Esomeprazole Capsule Sales by Region (2021-2026) & (K Pcs) Table 41. Global Esomeprazole Capsule Sales Market Share in Volume by Region (2021-2026) Table 42. Global Esomeprazole Capsule Sales by Region (2021-2026) & (US$ Million) Table 43. Global Esomeprazole Capsule Sales Market Share in Value by Region (2021-2026) Table 44. Global Esomeprazole Capsule Sales (K Pcs), Value (US$ Million), Price (US$/pc) and Gross Margin (2021-2026) Table 45. Global Esomeprazole Capsule Sales by Region (2027-2032) & (K Pcs) Table 46. Global Esomeprazole Capsule Sales Market Share in Volume by Region (2027-2032) Table 47. Global Esomeprazole Capsule Sales by Region (2027-2032) & (US$ Million) Table 48. Global Esomeprazole Capsule Sales Market Share in Value by Region (2027-2032) Table 49. Global Esomeprazole Capsule Sales (K Pcs), Value (US$ Million), Price (US$/pc) and Gross Margin (2027-2032) Table 50. Global Esomeprazole Capsule Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Esomeprazole Capsule Sales by Application (2021-2026) & (K Pcs) Table 52. Global Esomeprazole Capsule Sales Market Share in Volume by Application (2021-2026) Table 53. Global Esomeprazole Capsule Sales by Application (2021-2026) & (US$ Million) Table 54. Global Esomeprazole Capsule Sales Market Share in Value by Application (2021-2026) Table 55. Global Esomeprazole Capsule Price by Application (2021-2026) & (US$/pc) Table 56. Global Esomeprazole Capsule Sales by Application (2027-2032) & (K Pcs) Table 57. Global Esomeprazole Capsule Sales Market Share in Volume by Application (2027-2032) Table 58. Global Esomeprazole Capsule Sales by Application (2027-2032) & (US$ Million) Table 59. Global Esomeprazole Capsule Sales Market Share in Value by Application (2027-2032) Table 60. Global Esomeprazole Capsule Price by Application (2027-2032) & (US$/pc) Table 61. North America Esomeprazole Capsule Sales by Application (2021-2026) & (K Pcs) Table 62. North America Esomeprazole Capsule Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Esomeprazole Capsule Sales by Application (2021-2026) & (K Pcs) Table 64. Europe Esomeprazole Capsule Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Esomeprazole Capsule Sales by Application (2021-2026) & (K Pcs) Table 66. Asia-Pacific Esomeprazole Capsule Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Esomeprazole Capsule Sales by Application (2021-2026) & (K Pcs) Table 68. Latin America Esomeprazole Capsule Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Esomeprazole Capsule Sales by Application (2021-2026) & (K Pcs) Table 70. Middle East and Africa Esomeprazole Capsule Sales by Application (2021-2026) & (US$ Million) Table 71. Teva. Company Information Table 72. Teva. Business Overview Table 73. Teva. Esomeprazole Capsule Sales (K Pcs), Revenue (US$ Million), Price (US$/pc) and Gross Margin (2021-2026) Table 74. Teva. Esomeprazole Capsule Product Portfolio Table 75. Teva. Recent Development Table 76. Sandoz Company Information Table 77. Sandoz Business Overview Table 78. Sandoz Esomeprazole Capsule Sales (K Pcs), Revenue (US$ Million), Price (US$/pc) and Gross Margin (2021-2026) Table 79. Sandoz Esomeprazole Capsule Product Portfolio Table 80. Sandoz Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi Esomeprazole Capsule Sales (K Pcs), Revenue (US$ Million), Price (US$/pc) and Gross Margin (2021-2026) Table 84. Sanofi Esomeprazole Capsule Product Portfolio Table 85. Sanofi Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis Esomeprazole Capsule Sales (K Pcs), Revenue (US$ Million), Price (US$/pc) and Gross Margin (2021-2026) Table 89. Novartis Esomeprazole Capsule Product Portfolio Table 90. Novartis Recent Development Table 91. Mylan Company Information Table 92. Mylan Business Overview Table 93. Mylan Esomeprazole Capsule Sales (K Pcs), Revenue (US$ Million), Price (US$/pc) and Gross Margin (2021-2026) Table 94. Mylan Esomeprazole Capsule Product Portfolio Table 95. Mylan Recent Development Table 96. Stada Company Information Table 97. Stada Business Overview Table 98. Stada Esomeprazole Capsule Sales (K Pcs), Revenue (US$ Million), Price (US$/pc) and Gross Margin (2021-2026) Table 99. Stada Esomeprazole Capsule Product Portfolio Table 100. Stada Recent Development Table 101. Saval Pharmaceutical Company Information Table 102. Saval Pharmaceutical Business Overview Table 103. Saval Pharmaceutical Esomeprazole Capsule Sales (K Pcs), Revenue (US$ Million), Price (US$/pc) and Gross Margin (2021-2026) Table 104. Saval Pharmaceutical Esomeprazole Capsule Product Portfolio Table 105. Saval Pharmaceutical Recent Development Table 106. Mepha Company Information Table 107. Mepha Business Overview Table 108. Mepha Esomeprazole Capsule Sales (K Pcs), Revenue (US$ Million), Price (US$/pc) and Gross Margin (2021-2026) Table 109. Mepha Esomeprazole Capsule Product Portfolio Table 110. Mepha Recent Development Table 111. KernPharm Company Information Table 112. KernPharm Business Overview Table 113. KernPharm Esomeprazole Capsule Sales (K Pcs), Revenue (US$ Million), Price (US$/pc) and Gross Margin (2021-2026) Table 114. KernPharm Esomeprazole Capsule Product Portfolio Table 115. KernPharm Recent Development Table 116. Garmish Pharmaceuticals Company Information Table 117. Garmish Pharmaceuticals Business Overview Table 118. Garmish Pharmaceuticals Esomeprazole Capsule Sales (K Pcs), Revenue (US$ Million), Price (US$/pc) and Gross Margin (2021-2026) Table 119. Garmish Pharmaceuticals Esomeprazole Capsule Product Portfolio Table 120. Garmish Pharmaceuticals Recent Development Table 121. CQ Lummy Company Information Table 122. CQ Lummy Business Overview Table 123. CQ Lummy Esomeprazole Capsule Sales (K Pcs), Revenue (US$ Million), Price (US$/pc) and Gross Margin (2021-2026) Table 124. CQ Lummy Esomeprazole Capsule Product Portfolio Table 125. CQ Lummy Recent Development Table 126. Blaskov Company Information Table 127. Blaskov Business Overview Table 128. Blaskov Esomeprazole Capsule Sales (K Pcs), Revenue (US$ Million), Price (US$/pc) and Gross Margin (2021-2026) Table 129. Blaskov Esomeprazole Capsule Product Portfolio Table 130. Blaskov Recent Development Table 131. AstraZeneca AB Company Information Table 132. AstraZeneca AB Business Overview Table 133. AstraZeneca AB Esomeprazole Capsule Sales (K Pcs), Revenue (US$ Million), Price (US$/pc) and Gross Margin (2021-2026) Table 134. AstraZeneca AB Esomeprazole Capsule Product Portfolio Table 135. AstraZeneca AB Recent Development Table 136. Actavis Company Information Table 137. Actavis Business Overview Table 138. Actavis Esomeprazole Capsule Sales (K Pcs), Revenue (US$ Million), Price (US$/pc) and Gross Margin (2021-2026) Table 139. Actavis Esomeprazole Capsule Product Portfolio Table 140. Actavis Recent Development Table 141. North America Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 142. North America Esomeprazole Capsule Sales by Country (2021-2026) & (K Pcs) Table 143. North America Esomeprazole Capsule Sales Market Share by Country (2021-2026) Table 144. North America Esomeprazole Capsule Sales Forecast by Country (2027-2032) & (K Pcs) Table 145. North America Esomeprazole Capsule Sales Market Share Forecast by Country (2027-2032) Table 146. North America Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Esomeprazole Capsule Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Esomeprazole Capsule Market Share by Country (2021-2026) Table 149. North America Esomeprazole Capsule Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Esomeprazole Capsule Market Share Forecast by Country (2027-2032) Table 151. Europe Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 152. Europe Esomeprazole Capsule Sales by Country (2021-2026) & (K Pcs) Table 153. Europe Esomeprazole Capsule Sales Market Share by Country (2021-2026) Table 154. Europe Esomeprazole Capsule Sales Forecast by Country (2027-2032) & (K Pcs) Table 155. Europe Esomeprazole Capsule Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Esomeprazole Capsule Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Esomeprazole Capsule Market Share by Country (2021-2026) Table 159. Europe Esomeprazole Capsule Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Esomeprazole Capsule Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Esomeprazole Capsule Sales by Country (2021-2026) & (K Pcs) Table 163. Asia-Pacific Esomeprazole Capsule Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Esomeprazole Capsule Sales Forecast by Country (2027-2032) & (K Pcs) Table 165. Asia-Pacific Esomeprazole Capsule Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Esomeprazole Capsule Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Esomeprazole Capsule Market Share by Country (2021-2026) Table 169. Asia-Pacific Esomeprazole Capsule Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Esomeprazole Capsule Market Share Forecast by Country (2027-2032) Table 171. Latin America Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 172. Latin America Esomeprazole Capsule Sales by Country (2021-2026) & (K Pcs) Table 173. Latin America Esomeprazole Capsule Sales Market Share by Country (2021-2026) Table 174. Latin America Esomeprazole Capsule Sales Forecast by Country (2027-2032) & (K Pcs) Table 175. Latin America Esomeprazole Capsule Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Esomeprazole Capsule Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Esomeprazole Capsule Market Share by Country (2021-2026) Table 179. Latin America Esomeprazole Capsule Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Esomeprazole Capsule Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Esomeprazole Capsule Sales by Country (2021-2026) & (K Pcs) Table 183. Middle East and Africa Esomeprazole Capsule Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Esomeprazole Capsule Sales Forecast by Country (2027-2032) & (K Pcs) Table 185. Middle East and Africa Esomeprazole Capsule Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Esomeprazole Capsule Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Esomeprazole Capsule Market Share by Country (2021-2026) Table 189. Middle East and Africa Esomeprazole Capsule Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Esomeprazole Capsule Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Esomeprazole Capsule Distributors List Table 194. Esomeprazole Capsule Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Esomeprazole Capsule Image Figure 2. Global Esomeprazole Capsule Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Esomeprazole Capsule Market Size (2021-2032) & (US$ Million) Figure 4. Global Esomeprazole Capsule Sales (2021-2032) & (K Pcs) Figure 5. Short-Term Use Image Figure 6. Global Short-Term Use Sales YoY Growth (2021-2032) & (K Pcs) Figure 7. Long-Term Use Image Figure 8. Global Long-Term Use Sales YoY Growth (2021-2032) & (K Pcs) Figure 9. Global Esomeprazole Capsule Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Esomeprazole Capsule Market Share by Type 2025 VS 2032 Figure 11. North America Esomeprazole Capsule Sales Market Share in Volume by Type in 2025 Figure 12. North America Esomeprazole Capsule Sales Market Share in Value by Type in 2025 Figure 13. Europe Esomeprazole Capsule Sales Market Share in Volume by Type in 2025 Figure 14. Europe Esomeprazole Capsule Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Esomeprazole Capsule Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Esomeprazole Capsule Sales Market Share in Value by Type in 2025 Figure 17. Latin America Esomeprazole Capsule Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Esomeprazole Capsule Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Esomeprazole Capsule Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Esomeprazole Capsule Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Esomeprazole Capsule Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Duodenal Ulcers Image Figure 24. Global Duodenal Ulcers Sales YoY Growth (2021-2032) & (K Pcs) Figure 25. Gastroesophageal Reflux Disease Image Figure 26. Global Gastroesophageal Reflux Disease Sales YoY Growth (2021-2032) & (K Pcs) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Pcs) Figure 29. Global Esomeprazole Capsule Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Esomeprazole Capsule Market Share by Application 2025 VS 2032 Figure 31. North America Esomeprazole Capsule Sales Market Share in Volume by Application in 2025 Figure 32. North America Esomeprazole Capsule Sales Market Share in Value by Application in 2025 Figure 33. Europe Esomeprazole Capsule Sales Market Share in Volume by Application in 2025 Figure 34. Europe Esomeprazole Capsule Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Esomeprazole Capsule Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Esomeprazole Capsule Sales Market Share in Value by Application in 2025 Figure 37. Latin America Esomeprazole Capsule Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Esomeprazole Capsule Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Esomeprazole Capsule Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Esomeprazole Capsule Sales Market Share in Value by Application in 2025 Figure 41. North America Esomeprazole Capsule Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 42. North America Esomeprazole Capsule Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Esomeprazole Capsule Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Esomeprazole Capsule Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Esomeprazole Capsule Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 46. Europe Esomeprazole Capsule Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Esomeprazole Capsule Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Esomeprazole Capsule Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Esomeprazole Capsule Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 50. Asia-Pacific Esomeprazole Capsule Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Esomeprazole Capsule Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Esomeprazole Capsule Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Esomeprazole Capsule Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 54. Latin America Esomeprazole Capsule Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Esomeprazole Capsule Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Esomeprazole Capsule Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Esomeprazole Capsule Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 58. Middle East and Africa Esomeprazole Capsule Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Esomeprazole Capsule Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Esomeprazole Capsule Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Esomeprazole Capsule Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Esomeprazole Capsule Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Short-Term Use
  • Long-Term Use
Applications
  • Duodenal Ulcers
  • Gastroesophageal Reflux Disease
  • Others
Companies covered
  • Teva.
  • Sandoz
  • Sanofi
  • Novartis
  • Mylan
  • Stada
  • Saval Pharmaceutical
  • Mepha
  • KernPharm
  • Garmish Pharmaceuticals
  • CQ Lummy
  • Blaskov
  • AstraZeneca AB
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Esomeprazole Capsule Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Esomeprazole Capsule Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Esomeprazole Capsule Market by Type
  6. 1.3.1 Short-Term Use
  7. 1.3.2 Long-Term Use
  8. 1.4 Global Esomeprazole Capsule Market Size by Type
  9. 1.4.1 Global Esomeprazole Capsule Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Esomeprazole Capsule Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Esomeprazole Capsule Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Esomeprazole Capsule Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Esomeprazole Capsule Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Esomeprazole Capsule Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Esomeprazole Capsule Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Esomeprazole Capsule Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Esomeprazole Capsule Industry Trends
  2. 2.2 Esomeprazole Capsule Industry Drivers
  3. 2.3 Esomeprazole Capsule Industry Opportunities and Challenges
  4. 2.4 Esomeprazole Capsule Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Esomeprazole Capsule Revenue (2021-2026)
  2. 3.2 Global Top Players by Esomeprazole Capsule Sales (2021-2026)
  3. 3.3 Global Top Players by Esomeprazole Capsule Price (2021-2026)
  4. 3.4 Global Esomeprazole Capsule Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Esomeprazole Capsule Major Company Production Sites & Headquarters
  6. 3.6 Global Esomeprazole Capsule Company, Product Type & Application
  7. 3.7 Global Esomeprazole Capsule Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Esomeprazole Capsule Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Esomeprazole Capsule Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Esomeprazole Capsule Tier 1, Tier 2, and Tier 3
4 Esomeprazole Capsule Regional Status and Outlook
  1. 4.1 Global Esomeprazole Capsule Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Esomeprazole Capsule Historic Market Size by Region
  3. 4.2.1 Global Esomeprazole Capsule Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Esomeprazole Capsule Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Esomeprazole Capsule Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Esomeprazole Capsule Forecasted Market Size by Region
  7. 4.3.1 Global Esomeprazole Capsule Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Esomeprazole Capsule Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Esomeprazole Capsule Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Esomeprazole Capsule by Application
  1. 5.1 Esomeprazole Capsule Market by Application
  2. 5.1.1 Duodenal Ulcers
  3. 5.1.2 Gastroesophageal Reflux Disease
  4. 5.1.3 Others
  5. 5.2 Global Esomeprazole Capsule Market Size by Application
  6. 5.2.1 Global Esomeprazole Capsule Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Esomeprazole Capsule Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Esomeprazole Capsule Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Esomeprazole Capsule Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Esomeprazole Capsule Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Esomeprazole Capsule Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Esomeprazole Capsule Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Esomeprazole Capsule Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva.
  2. 6.1.1 Teva. Company Information
  3. 6.1.2 Teva. Business Overview
  4. 6.1.3 Teva. Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva. Esomeprazole Capsule Product Portfolio
  6. 6.1.5 Teva. Recent Developments
  7. 6.2 Sandoz
  8. 6.2.1 Sandoz Company Information
  9. 6.2.2 Sandoz Business Overview
  10. 6.2.3 Sandoz Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz Esomeprazole Capsule Product Portfolio
  12. 6.2.5 Sandoz Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Esomeprazole Capsule Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Esomeprazole Capsule Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Mylan
  26. 6.5.1 Mylan Company Information
  27. 6.5.2 Mylan Business Overview
  28. 6.5.3 Mylan Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan Esomeprazole Capsule Product Portfolio
  30. 6.5.5 Mylan Recent Developments
  31. 6.6 Stada
  32. 6.6.1 Stada Company Information
  33. 6.6.2 Stada Business Overview
  34. 6.6.3 Stada Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Stada Esomeprazole Capsule Product Portfolio
  36. 6.6.5 Stada Recent Developments
  37. 6.7 Saval Pharmaceutical
  38. 6.7.1 Saval Pharmaceutical Company Information
  39. 6.7.2 Saval Pharmaceutical Business Overview
  40. 6.7.3 Saval Pharmaceutical Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Saval Pharmaceutical Esomeprazole Capsule Product Portfolio
  42. 6.7.5 Saval Pharmaceutical Recent Developments
  43. 6.8 Mepha
  44. 6.8.1 Mepha Company Information
  45. 6.8.2 Mepha Business Overview
  46. 6.8.3 Mepha Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mepha Esomeprazole Capsule Product Portfolio
  48. 6.8.5 Mepha Recent Developments
  49. 6.9 KernPharm
  50. 6.9.1 KernPharm Company Information
  51. 6.9.2 KernPharm Business Overview
  52. 6.9.3 KernPharm Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 KernPharm Esomeprazole Capsule Product Portfolio
  54. 6.9.5 KernPharm Recent Developments
  55. 6.10 Garmish Pharmaceuticals
  56. 6.10.1 Garmish Pharmaceuticals Company Information
  57. 6.10.2 Garmish Pharmaceuticals Business Overview
  58. 6.10.3 Garmish Pharmaceuticals Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Garmish Pharmaceuticals Esomeprazole Capsule Product Portfolio
  60. 6.10.5 Garmish Pharmaceuticals Recent Developments
  61. 6.11 CQ Lummy
  62. 6.11.1 CQ Lummy Company Information
  63. 6.11.2 CQ Lummy Business Overview
  64. 6.11.3 CQ Lummy Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CQ Lummy Esomeprazole Capsule Product Portfolio
  66. 6.11.5 CQ Lummy Recent Developments
  67. 6.12 Blaskov
  68. 6.12.1 Blaskov Company Information
  69. 6.12.2 Blaskov Business Overview
  70. 6.12.3 Blaskov Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Blaskov Esomeprazole Capsule Product Portfolio
  72. 6.12.5 Blaskov Recent Developments
  73. 6.13 AstraZeneca AB
  74. 6.13.1 AstraZeneca AB Company Information
  75. 6.13.2 AstraZeneca AB Business Overview
  76. 6.13.3 AstraZeneca AB Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 AstraZeneca AB Esomeprazole Capsule Product Portfolio
  78. 6.13.5 AstraZeneca AB Recent Developments
  79. 6.14 Actavis
  80. 6.14.1 Actavis Company Information
  81. 6.14.2 Actavis Business Overview
  82. 6.14.3 Actavis Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Actavis Esomeprazole Capsule Product Portfolio
  84. 6.14.5 Actavis Recent Developments
7 North America by Country
  1. 7.1 North America Esomeprazole Capsule Sales by Country
  2. 7.1.1 North America Esomeprazole Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Esomeprazole Capsule Sales by Country (2021-2026)
  4. 7.1.3 North America Esomeprazole Capsule Sales Forecast by Country (2027-2032)
  5. 7.2 North America Esomeprazole Capsule Market Size by Country
  6. 7.2.1 North America Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Esomeprazole Capsule Market Size by Country (2021-2026)
  8. 7.2.3 North America Esomeprazole Capsule Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Esomeprazole Capsule Sales by Country
  2. 8.1.1 Europe Esomeprazole Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Esomeprazole Capsule Sales by Country (2021-2026)
  4. 8.1.3 Europe Esomeprazole Capsule Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Esomeprazole Capsule Market Size by Country
  6. 8.2.1 Europe Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Esomeprazole Capsule Market Size by Country (2021-2026)
  8. 8.2.3 Europe Esomeprazole Capsule Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Esomeprazole Capsule Sales by Country
  2. 9.1.1 Asia-Pacific Esomeprazole Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Esomeprazole Capsule Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Esomeprazole Capsule Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Esomeprazole Capsule Market Size by Country
  6. 9.2.1 Asia-Pacific Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Esomeprazole Capsule Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Esomeprazole Capsule Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Esomeprazole Capsule Sales by Country
  2. 10.1.1 South America Esomeprazole Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Esomeprazole Capsule Sales by Country (2021-2026)
  4. 10.1.3 South America Esomeprazole Capsule Sales Forecast by Country (2027-2032)
  5. 10.2 South America Esomeprazole Capsule Market Size by Country
  6. 10.2.1 South America Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Esomeprazole Capsule Market Size by Country (2021-2026)
  8. 10.2.3 South America Esomeprazole Capsule Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Esomeprazole Capsule Sales by Country
  2. 11.1.1 Middle East and Africa Esomeprazole Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Esomeprazole Capsule Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Esomeprazole Capsule Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Esomeprazole Capsule Market Size by Country
  6. 11.2.1 Middle East and Africa Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Esomeprazole Capsule Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Esomeprazole Capsule Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Esomeprazole Capsule Value Chain Analysis
  2. 12.1.1 Esomeprazole Capsule Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Esomeprazole Capsule Production Mode & Process
  7. 12.2 Esomeprazole Capsule Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Esomeprazole Capsule Distributors
  10. 12.2.3 Esomeprazole Capsule Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research